AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9391220 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 trials of tactile-thermal application (TTA)
Number of subjects: 0
Study 9391220 — intervention group
Group type: EXPERIMENTAL
Intervention: 450 trials of tactile-thermal application (TTA)
Number of subjects: 0
Study 9391220 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 trials of tactile-thermal application (TTA)
Number of subjects: 0
Study 7502689 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinylestradiol 20 micrograms/day + calcium 500 mg/day
Number of subjects: 41
Study 7502689 — intervention group
Group type: COMPARATOR
Intervention: Calcium 500 mg/day
Number of subjects: 41
Study 2091186 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrolyte‐polyethylene glycol solution (SE‐PEG)
Number of subjects: 0
Study 2091186 — intervention group
Group type: COMPARATOR
Intervention: Standard bowel preparation (SBP)
Number of subjects: 0
Study 354046 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk
Number of subjects: 48
Study 354046 — intervention group
Group type: COMPARATOR
Intervention: Soya-maize porridge
Number of subjects: 48
Study 31948477 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-magnitude high-frequency vibration (LMHFV)
Number of subjects: 200
Study 31948477 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study 31099593 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of listeriosis
Number of subjects: 397
Study 31099593 — intervention group
Group type: EXPERIMENTAL
Intervention: Attitude toward listeriosis
Number of subjects: 397
Study 31099593 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice formation regarding listeriosis
Number of subjects: 397
Study 31099593 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge-Attitude-Practice (KAP) score
Number of subjects: 397
Study 31099593 — intervention group
Group type: EXPERIMENTAL
Intervention: Association between attitude and knowledge
Number of subjects: 397
Study 31099593 — intervention group
Group type: EXPERIMENTAL
Intervention: Association between practice formation and knowledge
Number of subjects: 397
Study 31099593 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of KAP scores with age, occupation, department, and professional title
Number of subjects: 397
Study 28237552 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT)
Number of subjects: 15
Study 28237552 — intervention group
Group type: COMPARATOR
Intervention: Traditional speech therapy
Number of subjects: 15
Study 25818495 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline Q waves in men
Number of subjects: 2838
Study 25818495 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline Q waves in women
Number of subjects: 2838
Study 25818495 — intervention group
Group type: EXPERIMENTAL
Intervention: Time from symptom onset to PCI in women with baseline Q waves
Number of subjects: 2838
Study 23652626 — intervention group
Group type: EXPERIMENTAL
Intervention: Better collateral flow at baseline
Number of subjects: 88
Study 23652626 — intervention group
Group type: EXPERIMENTAL
Intervention: Deterioration in collateral quality
Number of subjects: 88
Study 23652626 — intervention group
Group type: EXPERIMENTAL
Intervention: Deterioration in collateral grade
Number of subjects: 88
Study 23652626 — intervention group
Group type: EXPERIMENTAL
Intervention: Deterioration in Tmax hypoperfusion severity
Number of subjects: 88
Study 21861909 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared medical appointments
Number of subjects: 300
Study 21861909 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 300
Study 19930019 — intervention group
Group type: EXPERIMENTAL
Intervention: 2004 Canadian Addictions Survey (CAS)
Number of subjects: 0
Study 19930019 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustment for non-response bias
Number of subjects: 0
Study 19930019 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate logistic regression
Number of subjects: 0
Study 17709712 — intervention group
Group type: EXPERIMENTAL
Intervention: POTS patients
Number of subjects: 165
Study 17709712 — intervention group
Group type: EXPERIMENTAL
Intervention: POTS patients with high NE
Number of subjects: 165
Study 17709712 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 165
Study 15096071 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine, 100 to 200 mg/day for 12 months
Number of subjects: 225
Study 15096071 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 months
Number of subjects: 225
Study 15096071 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 225
Study 15096071 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 225
Study 11774146 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine solution via an infusion pump (2 mL each hour for 48 hours)
Number of subjects: 50
Study 11774146 — intervention group
Group type: COMPARATOR
Intervention: Saline solution via an infusion pump (2 mL each hour for 48 hours)
Number of subjects: 50
Study 11477812 — intervention group
Group type: EXPERIMENTAL
Intervention: Buyang Huanwu Decoction (BHD) in Chinese medicine group (CMG)
Number of subjects: 70
Study 11477812 — intervention group
Group type: COMPARATOR
Intervention: Hydroxyethyl starch injection and enteric coated aspirin tablets in western medicine group (WMG)
Number of subjects: 70
Study 7650234 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (200 mg) plus adrenalin (1:200,000)
Number of subjects: 10
Study 7650234 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine (200 mg)
Number of subjects: 10
Study 2813924 — intervention group
Group type: EXPERIMENTAL
Intervention: Elimination diet and double-blind challenge test
Number of subjects: 22
Study 2813924 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical evaluation of nasal polyposis
Number of subjects: 22
Study 2813924 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhinomanometric evaluation
Number of subjects: 22
Study 2813924 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunological tests involving IgE or circulating immunocomplexes
Number of subjects: 22
Study 47848 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient methadone detoxification
Number of subjects: 40
Study 47848 — intervention group
Group type: COMPARATOR
Intervention: Hospital methadone detoxification
Number of subjects: 40
Study 29858659 — intervention group
Group type: EXPERIMENTAL
Intervention: Gaseous ozone
Number of subjects: 48
Study 29858659 — intervention group
Group type: COMPARATOR
Intervention: 2% chlorhexidine
Number of subjects: 48
Study 29858659 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 48
Study 29454656 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to music during cast room procedures
Number of subjects: 199
Study 29454656 — intervention group
Group type: COMPARATOR
Intervention: No music during cast room procedures
Number of subjects: 199
Study 26892922 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil (400 mg/day for 26 days, then 300 mg/day for 30 days, and 200 mg/day for 31 days)
Number of subjects: 29
Study 26892922 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 26892922 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 29
Study 24562805 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 3602
Study 24562805 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 3602
Study 24562805 — intervention group
Group type: COMPARATOR
Intervention: Severely impaired LVEF (<40%)
Number of subjects: 3602
Study 22309385 — intervention group
Group type: EXPERIMENTAL
Intervention: Chin-down posture
Number of subjects: 47
Study 21073082 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of Gentamycin 80 mg IV (immediately after spinal anesthesia)
Number of subjects: 722
Study 21073082 — intervention group
Group type: COMPARATOR
Intervention: Extended use of Amoxicillin, Chloramphenicol or Cotrimexazole (postoperatively)
Number of subjects: 722
Study 21073082 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of Gentamycin 80 mg IV
Number of subjects: 722
Study 21073082 — intervention group
Group type: COMPARATOR
Intervention: Extended use of Amoxicillin, Chloramphenicol or Cotrimexazole
Number of subjects: 722
Study 17981377 — intervention group
Group type: EXPERIMENTAL
Intervention: Purified duck embryo vaccine (PDEV, Vaxirab)
Number of subjects: 220
Study 17981377 — intervention group
Group type: COMPARATOR
Intervention: Purified duck embryo vaccine (Lyssavac)
Number of subjects: 220
Study 15727886 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 8
Study 15727886 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 12541217 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional phototherapy (CPT)
Number of subjects: 41
Study 12541217 — intervention group
Group type: COMPARATOR
Intervention: Fiberoptic phototherapy (FO-PT)
Number of subjects: 41
Study 9842767 — intervention group
Group type: EXPERIMENTAL
Intervention: Lesions to the right parahippocampal cortex
Number of subjects: 0
Study 9842767 — intervention group
Group type: EXPERIMENTAL
Intervention: Lesions to the right hippocampus
Number of subjects: 0
Study 9842767 — intervention group
Group type: EXPERIMENTAL
Intervention: Lesions to the left hippocampus
Number of subjects: 0
Study 7859239 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release Uni-Dur 600-mg theophylline tablet to fasting subjects
Number of subjects: 0
Study 7859239 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release Uni-Dur 600-mg tablet after a high-fat meal
Number of subjects: 0
Study 7859239 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release Uni-Dur 600-mg dose administered as two half tablets to fasting subjects
Number of subjects: 0
Study 7859239 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release Uni-Dur 400-mg tablet to fasting subjects
Number of subjects: 0
Study 7859239 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release theophylline (Slo-Phyllin) 5 x 100 mg to fasting subjects
Number of subjects: 0
Study 7859239 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release Uni-Dur 600-mg fasting treatment
Number of subjects: 0
Study 7859239 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release Uni-Dur 400-mg treatment
Number of subjects: 0
Study 2570730 — intervention group
Group type: EXPERIMENTAL
Intervention: famotidine (40 mg at bedtime)
Number of subjects: 157
Study 2570730 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 157
Study 786440 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 81
Study 786440 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 31082445 — intervention group
Group type: EXPERIMENTAL
Intervention: 3STEPFUN intervention (small group education, foot care kit, booster calls over 6 months)
Number of subjects: 119
Study 31082445 — intervention group
Group type: EXPERIMENTAL
Intervention: 3STEPFUN intervention
Number of subjects: 119
Study 31082445 — intervention group
Group type: COMPARATOR
Intervention: Usual care and foot care brochure (control group)
Number of subjects: 119
Study 28222072 — intervention group
Group type: EXPERIMENTAL
Intervention: Central re-testing of receptor status
Number of subjects: 431
Study 26130251 — intervention group
Group type: EXPERIMENTAL
Intervention: S-Adenosylmethionine (SAMe) 2.4 g/d for 24 weeks
Number of subjects: 110
Study 26130251 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 26130251 — intervention group
Group type: EXPERIMENTAL
Intervention: S-Adenosylmethionine (SAMe)
Number of subjects: 110
Study 24277402 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral plus parenteral nutrition (EN+PN)
Number of subjects: 120
Study 24277402 — intervention group
Group type: COMPARATOR
Intervention: Total parenteral nutrition (TPN)
Number of subjects: 120
Study 24277402 — intervention group
Group type: EXPERIMENTAL
Intervention: Total enteral nutrition (TEN)
Number of subjects: 120
Study 21615968 — intervention group
Group type: COMPARATOR
Intervention: GP management alone
Number of subjects: 169
Study 21615968 — intervention group
Group type: EXPERIMENTAL
Intervention: GP management with adjunctive counselling (CBT)
Number of subjects: 169
Study 21615968 — intervention group
Group type: EXPERIMENTAL
Intervention: GP management with adjunctive counselling (CBT) delivered by postnatal nurses or psychologists
Number of subjects: 169
Study 18362660 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin 0.5%
Number of subjects: 0
Study 18362660 — intervention group
Group type: COMPARATOR
Intervention: Gatifloxacin 0.3%
Number of subjects: 0
Study 16627675 — intervention group
Group type: EXPERIMENTAL
Intervention: NaHCO3 (Alk-T)
Number of subjects: 16
Study 16627675 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Pla-T)
Number of subjects: 16
Study 12752349 — intervention group
Group type: EXPERIMENTAL
Intervention: PAC (pantoprazole 40 mg, clarithromycin 500 mg, amoxicillin 1000 mg)
Number of subjects: 519
Study 12752349 — intervention group
Group type: EXPERIMENTAL
Intervention: PCM (pantoprazole 40 mg, clarithromycin 500 mg, metronidazole 500 mg)
Number of subjects: 519
Study 12752349 — intervention group
Group type: EXPERIMENTAL
Intervention: PAM (pantoprazole 40 mg, amoxicillin 1000 mg, metronidazole 500 mg)
Number of subjects: 519
Study 10936141 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventilator management protocol (VMP)
Number of subjects: 385
Study 10936141 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical VMP group
Number of subjects: 385
Study 10936141 — intervention group
Group type: COMPARATOR
Intervention: Control group (surgical)
Number of subjects: 385
Study 10936141 — intervention group
Group type: COMPARATOR
Intervention: Control group (medical)
Number of subjects: 385
Study 10936141 — intervention group
Group type: EXPERIMENTAL
Intervention: VMP and Control groups
Number of subjects: 385
Study 8820890 — intervention group
Group type: EXPERIMENTAL
Intervention: 22.2 g dibasic calcium phosphate (DCP)
Number of subjects: 12
Study 8820890 — intervention group
Group type: COMPARATOR
Intervention: Calcium carbonate (placebo)
Number of subjects: 12
Study 8213584 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 223
Study 8213584 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 223
Study 8213584 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 223
Study 3495089 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction 2 mg kg‐1, infusion rate 9 mg kg‐1 h‐1 (Group 1)
Number of subjects: 30
Study 3495089 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction 2.5 mg kg‐1, infusion rate 12 mg kg‐1 h‐1 (Group 2)
Number of subjects: 30
Study 3495089 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction 2.5 mg kg‐1, infusion rate 9 mg kg‐1 (Group 3)
Number of subjects: 30
Study 31734069 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 750
Study 31734069 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal ablation
Number of subjects: 750
Study 31734069 — intervention group
Group type: COMPARATOR
Intervention: LLETZ
Number of subjects: 750
Study 29959288 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoom2 (Z) with light activation
Number of subjects: 60
Study 29959288 — intervention group
Group type: COMPARATOR
Intervention: Boost (B) without light activation
Number of subjects: 60
Study 25496482 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidance plan (radiotherapy optimized to minimize dose to functional lung)
Number of subjects: 64
Study 25496482 — intervention group
Group type: COMPARATOR
Intervention: Standard plan (radiotherapy without reference to functional lung state)
Number of subjects: 64
Study 25496482 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidance plan
Number of subjects: 64
Study 25496482 — intervention group
Group type: COMPARATOR
Intervention: Standard plan
Number of subjects: 64
Study 22261206 — intervention group
Group type: EXPERIMENTAL
Intervention: Cybercycling (virtual reality tours on a recumbent stationary ergometer)
Number of subjects: 102
Study 22261206 — intervention group
Group type: COMPARATOR
Intervention: Traditional exercise
Number of subjects: 102
Study 22261206 — intervention group
Group type: EXPERIMENTAL
Intervention: Cybercycling
Number of subjects: 102
Study 20305044 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast track intervention (FI) - multiprofessional palliative care team assessment and follow-up
Number of subjects: 52
Study 20305044 — intervention group
Group type: COMPARATOR
Intervention: Standard intervention (SI) - best standard care followed by palliative care team after 3 months
Number of subjects: 52
Study 18354721 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthetic lumbar facet joint nerve blocks
Number of subjects: 120
Study 18354721 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthetic and steroid lumbar facet joint nerve blocks
Number of subjects: 120
Study 18354721 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 120
Study 15849292 — intervention group
Group type: EXPERIMENTAL
Intervention: Athletes
Number of subjects: 300
Study 15849292 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 300
Study 12414409 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mM trehalose
Number of subjects: 34
Study 12414409 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mM trehalose
Number of subjects: 34
Study 12414409 — intervention group
Group type: COMPARATOR
Intervention: Control saline
Number of subjects: 34
Study 10494113 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training
Number of subjects: 204
Study 10494113 — intervention group
Group type: EXPERIMENTAL
Intervention: Bladder training
Number of subjects: 204
Study 10494113 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination training (both pelvic floor muscle training and bladder training)
Number of subjects: 204
Study 10494113 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 204
Study 7563511 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentage of free PSA in serum in men with cancer and a normal‐sized gland
Number of subjects: 113
Study 7563511 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentage of free PSA in serum in men with cancer and an enlarged gland
Number of subjects: 113
Study 7563511 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentage of free PSA in serum in men with benign prostatic hyperplasia
Number of subjects: 113
Study 7563511 — intervention group
Group type: EXPERIMENTAL
Intervention: Free PSA cutoff in men with an enlarged, palpably benign gland
Number of subjects: 113
Study 2083477 — intervention group
Group type: EXPERIMENTAL
Intervention: Water Pik Automatic Toothbrush
Number of subjects: 30
Study 2083477 — intervention group
Group type: EXPERIMENTAL
Intervention: Interplak brush
Number of subjects: 30
Study 2083477 — intervention group
Group type: COMPARATOR
Intervention: Manual brushing
Number of subjects: 30
Study 368354 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine hydrochloride 200 mg daily
Number of subjects: 0
Study 31522846 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic supracervical hysterectomy
Number of subjects: 660
Study 31522846 — intervention group
Group type: COMPARATOR
Intervention: Endometrial ablation
Number of subjects: 660
Study 27770836 — intervention group
Group type: EXPERIMENTAL
Intervention: kJ/100g food label
Number of subjects: 0
Study 27770836 — intervention group
Group type: EXPERIMENTAL
Intervention: HSR label
Number of subjects: 0
Study 27770836 — intervention group
Group type: COMPARATOR
Intervention: No information on nutrient composition
Number of subjects: 0
Study 25755135 — intervention group
Group type: EXPERIMENTAL
Intervention: Low acculturation (SASH score < 3)
Number of subjects: 398
Study 23569021 — intervention group
Group type: EXPERIMENTAL
Intervention: High spinal anaesthesia with midazolam and fentanyl in older patients
Number of subjects: 90
Study 23569021 — intervention group
Group type: EXPERIMENTAL
Intervention: High spinal anaesthesia without midazolam and fentanyl in older patients
Number of subjects: 90
Study 23569021 — intervention group
Group type: COMPARATOR
Intervention: High spinal anaesthesia in younger patients
Number of subjects: 90
Study 22008819 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV vaccine (Rotarix™)
Number of subjects: 200
Study 22008819 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 22008819 — intervention group
Group type: EXPERIMENTAL
Intervention: Transmission cases
Number of subjects: 200
Study 19276131 — intervention group
Group type: EXPERIMENTAL
Intervention: Naftidrofuryl
Number of subjects: 1266
Study 19276131 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1266
Study 16620739 — intervention group
Group type: EXPERIMENTAL
Intervention: Checkpoints Program (intervention)
Number of subjects: 3743
Study 16620739 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 3743
Study 15452023 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acid supplementation (fish oil)
Number of subjects: 18
Study 15452023 — intervention group
Group type: COMPARATOR
Intervention: Olive oil capsules (control)
Number of subjects: 18
Study 11385189 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estrogen therapy (TET)
Number of subjects: 7
Study 9092956 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (TPM) at target dosages of 200-1,000 mg daily
Number of subjects: 534
Study 9092956 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (TPM)
Number of subjects: 534
Study 9092956 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 534
Study 7706568 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive model including variables of acute physiology and Glasgow Coma Score
Number of subjects: 901
Study 7706568 — intervention group
Group type: COMPARATOR
Intervention: Predictive model consisting of Glasgow Coma Score, age, diagnosis of head injury, and type of ICU admission
Number of subjects: 901
Study 3423501 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma exchange
Number of subjects: 0
Study 3423501 — intervention group
Group type: COMPARATOR
Intervention: Control group (no plasma exchange)
Number of subjects: 0
Study 28913575 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin degludec
Number of subjects: 0